P529: THE EFFECT OF AGE AND TREATMENT ON THE PREDICTIVE VALUE OF MEASURABLE RESIDUAL DISEASE: IMPLICATIONS FOR THE CLINICAL MANAGEMENT OF ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA

P529: THE EFFECT OF AGE AND TREATMENT ON THE PREDICTIVE VALUE OF MEASURABLE RESIDUAL DISEASE: IMPLICATIONS FOR THE CLINICAL MANAGEMENT OF ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA

Bibliographic Details
Main Authors:	Francesco Mannelli, Matteo Piccini, Sara Bencini, Giacomo Gianfaldoni, Benedetta Peruzzi, Roberto Caporale, Barbara Scappini, Laura Fasano, Elisa Quinti, Gaia Ciolli, Andrea Pasquini, Francesca Crupi, Sofia Pilerci, Fabiana Pancani, Leonardo Signori, Danilo Tarantino, Chiara Maccari, Vivian Paradiso, Francesco Annunziato, Paola Guglielmelli, Alessandro Maria Vannucchi
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000969024.54552.32

Similar Items

Effect of age and treatment on predictive value of measurable residual disease: implications for clinical management of adult patients with acute myeloid leukemia
by: Francesco Mannelli, et al.
Published: (2023-06-01)

Impact of baseline genetic profile and treatment on outcome and hematological toxicity in CEBPA-mutated AML
by: Francesco Mannelli, et al.
Published: (2025-03-01)

Prognostic stratification in venetoclax-based acute myeloid leukemia treatments: the molecular prognostic risk signature tested in a real-world setting
by: Gaia Ciolli, et al.
Published: (2024-09-01)

Successful rechallenge with Erwinia chrysanthemi asparaginase after pegaspargase-induced hypertriglyceridemia: a case report
by: Gaia Ciolli, et al.
Published: (2024-09-01)

Early reduction of WT1 transcripts during induction chemotherapy predicts for longer disease free and overall survival in acute myeloid leukemia
by: Giacomo Gianfaldoni, et al.
Published: (2010-05-01)

Differential prognostic impact of cytopenic phenotype in prefibrotic vs overt primary myelofibrosis
by: Giacomo Coltro, et al.
Published: (2022-08-01)

CEBPA–double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological features
by: Francesco Mannelli, et al.
Published: (2017-03-01)

P17 CLONAL PLASMA-CELLS IN STEM CELL APHERESIS AS A PREDICTOR OF PROGRESSION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS ELEGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTATION
by: S. Pilerci, et al.
Published: (2023-05-01)

One thousand patients with essential thrombocythemia: the Florence-CRIMM experience
by: Giuseppe G. Loscocco, et al.
Published: (2024-01-01)

529 & Education Savings Plans /
by: Munro, Margaret Atkins, author.
Published: (2023)

The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis
by: Francesco Mannelli, et al.
Published: (2023-10-01)

Validation and molecular integration of the RR6 model to predict survival after 6 months of therapy with ruxolitinib
by: Giacomo Coltro, et al.
Published: (2024-05-01)

On the Issue of Athens School Closing in 529 AD
by: Anna Mikhailovna Bolgova
Published: (2016-10-01)

P985: THE ALLELIC RATIO OF DRIVER AND ASXL1 MUTATIONS IS PROGNOSTICALLY RELEVANT IN PMF
by: G. Coltro, et al.
Published: (2022-06-01)

Kloning dan sekuensing gen 529 (R529) toxoplasma gondii isolat lokal untuk pengembangan metode diagnosis berbasis gen
by: Hartati, Sri, et al.
Published: (2011)

10 anos da Lei 12.529/2011
by: Amanda Athayde, et al.
Published: (2022-06-01)

The Role of Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Past, Present, and Future Directions
by: Matteo Piccini, et al.
Published: (2023-05-01)

Corrigendum to < Rapid evaluation of T cell clonality in the diagnostic work-up of mature T cell neoplasms: TRBC1-based flow cytometric assay experience><Translational Oncology, 26C (2022) 101552]>
by: Manuela Capone, et al.
Published: (2023-04-01)

Rapid evaluation of T cell clonality in the diagnostic work-up of mature T cell neoplasms: TRBC1-based flow cytometric assay experience
by: Manuela Capone, et al.
Published: (2022-12-01)

Molecular pathophysiology of Philadelphia-negative myeloproliferative disorders: beyond JAK2 and MPL mutations
by: Alessandro M. Vannucchi, et al.
Published: (2008-07-01)

Surgical resection of lung metastases: results from 529 patients
by: Riad N. Younes, et al.
Published: (2009-06-01)

Acknowledgement to reviewers, Metalurgija 59(2020)1-4, 1-529
by: Ilija Mamuzić
Published: (2021-01-01)

JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis
by: Paola Guglielmelli, et al.
Published: (2021-12-01)

Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey [Corrigendum]
by: Innocenti R, et al.
Published: (2019-02-01)

Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey
by: Innocenti R, et al.
Published: (2018-12-01)

529 Implementation of a Clinical Research Feasibility Program at an Academic Medical Center
by: Chin Chin Lee, et al.
Published: (2024-04-01)

Vaccination and Transmission Risk during the Outbreak of B.1.1.529 (Omicron)
by: Barbara Grüne, et al.
Published: (2022-06-01)

Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529)
by: June Young Chun, et al.
Published: (2022-11-01)

P5.29 PULSE TIMING DIFFERENTIAL AS A MEASURE OF ARTERIAL STIFFNESS
by: L.W. Winchester, et al.
Published: (2011-11-01)

CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
by: Paola Guglielmelli, et al.
Published: (2010-05-01)

CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
by: Lisa Pieri, et al.
Published: (2010-06-01)

HPLC and flow cytometry combined approach for HbF analysis in fetomaternal haemorrhage evaluation
by: Benedetta Peruzzi, et al.
Published: (2024-05-01)

Detection of toxoplasma gondii based on sequence r529 and sag1 gene probe
by: Kusumawati, Asmarani, et al.
Published: (2010)

Omicron Sub-Lineages (BA.1.1.529 + BA.*) Current Status in Ecuador
by: Andrés Carrazco-Montalvo, et al.
Published: (2022-05-01)

Havoc caused by the SARS-CoV-2 Omicron (B.1.1.529)
by: Prithiviraj Nagarajan, et al.
Published: (2022-07-01)

A survey of diseases in captive bearded dragons: a retrospective study of 529 patients
by: S. Schmidt-Ukaj, et al.
Published: (2017-09-01)

Cyril of Scythopolis on Relieving the Damage in Palestine Inflicted during the Samaritan Revolt (529–531)
by: Ireneusz Milewski
Published: (2022-12-01)

SBS 0802+529: A New Variable Star from the Second Byurakan Survey
by: Chavushyan V., et al.
Published: (2012-06-01)

Epidemiological description of 529 families referred for French transcultural psychotherapy: A decade of experience.
by: Jonathan Lachal, et al.
Published: (2020-01-01)

On the Thermodynamics of the <i>q</i>-Particles
by: Fabio Ciolli, et al.
Published: (2022-01-01)